StockData
DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc. (DMAC) income statement

DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$8.59+0.21 (+2.51%)

Close on Nov 18, 2026Market cap $463.22MP/E –Yield –

See a number that looks wrong?